The Senate Judiciary Committee on Thursday (May 24) voted to send five opioid-related bills to the Senate floor, including a measure that would require the Drug Enforcement Administration (DEA) to consider diversion, abuse and other public health impacts of opioids when setting annual production quotas for manufacturers.
NON-SUBSCRIBER OPTIONS
FREE TRIAL | NEWSSTAND
GET 30 DAYS FREE
The next health policy debate begins now, and the future direction of health reform seems more uncertain than ever. Now is the time to take advantage of the detailed, forward-looking reporting that only Inside Health Policy delivers.
Sign up for 30 days of no-obligation access for all the essential news during this critical time.
Home
Top Story
CBO Estimates Trump’s DME Bidding Plan Would Cost $1.3B, OMB Says It Would Save $6.5B
The Congressional Budget Office estimates that a proposal in the president's fiscal 2019 budget to expand and reform competitive bidding for durable medical equipment would cost $1.3 billion over 10 years, a stark contrast to HHS’ estimate the plan would save $6.5 billion over the same time period.
Latest News
A coalition of the nation's largest pharmacies are suing Allergan over what they alleged is a multiyear anticompetitive scheme to shield the company's dry eye drug Restasis from generic competition.
Spending on cancer drugs doubled in the past five years and is expected to double again in the next five years, but employers paid most of the increased costs.
A new survey published by a precision medicine stakeholder group shows that, while most Americans have never heard of personalized or precision medicine, most had positive reactions when they were told what it was.
The president’s 2019 Budget would reduce federal spending for health care by $1.3 trillion, or 8 percent, through 2028, the Congressional Budget Office (CBO) concluded in a newly issued report.
The Senate Appropriations Committee on Thursday (May 24) voted to send to the Senate floor a fiscal 2019 FDA funding bill that appears to give the agency $163 million more than its current level but still less than requested by the administration, coming after House appropriators also agreed to hike FDA spending.
A new survey published by a precision medicine stakeholder group shows that, while most Americans have never heard of personalized or precision medicine, most had positive reactions when they were told what it was.
A state judge in Maine said Thursday (May 24) she plans to rule as quickly as possible on whether the state is breaking the law by failing to enact voter-approved Medicaid expansion.
FDA Commissioner Scott Gottlieb is inviting internet stakeholders, including senior executives of major search engines, social media platforms, domain names registries and online marketplaces, to an opioid summit on June 27 to discuss ways to reduce illegal online opioid sales.
CMS will soon request proposals from third parties to buy drugs on behalf of physicians, which is a defunct program HHS is reviving for the first...
Despite the Trump administration's attempts to dismantle the Affordable Care Act last year, newly released government data show the national...
The Senate Appropriations Committee on Thursday (May 24) voted to send to the Senate floor a fiscal 2019 FDA funding bill that appears to give the...
© 2002-2018. Inside Washington Publishers | Contact Us